skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:062308/0405   Pages: 7
Recorded: 01/09/2023
Attorney Dkt #:8555.9999GEN
Conveyance: RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Total properties: 42
1
Patent #:
9809654
Issue Dt:
11/07/2017
Application #:
10529221
Filing Dt:
06/30/2006
Publication #:
US20060269540
Pub Dt:
11/30/2006
Title:
Targeted cd1d molecules
2
Patent #:
9382327
Issue Dt:
07/05/2016
Application #:
11869170
Filing Dt:
10/09/2007
Publication #:
US20090130089
Pub Dt:
05/21/2009
Title:
ANTI-CD20 ANTIBODIES AND METHODS OF USE
3
Patent #:
7919594
Issue Dt:
04/05/2011
Application #:
12030356
Filing Dt:
02/13/2008
Publication #:
US20080219971
Pub Dt:
09/11/2008
Title:
HUMAN ANTI-CD100 ANTIBODIES
4
Patent #:
9603922
Issue Dt:
03/28/2017
Application #:
12034737
Filing Dt:
02/21/2008
Publication #:
US20080254045
Pub Dt:
10/16/2008
Title:
Modulation of NKT Cell Activity with Antigen-Loaded CD1d Molecules
5
Patent #:
8496938
Issue Dt:
07/30/2013
Application #:
12776187
Filing Dt:
05/07/2010
Publication #:
US20100285036
Pub Dt:
11/11/2010
Title:
ANTI-CD100 NEUTRALIZING ANTIBODIES AND METHODS OF USING THE SAME
6
Patent #:
8816058
Issue Dt:
08/26/2014
Application #:
13517807
Filing Dt:
06/14/2012
Publication #:
US20120270268
Pub Dt:
10/25/2012
Title:
Polynucleotides Encoding Anti-CD100 Antibodies or Antigen-binding Fragments Thereof
7
Patent #:
8834883
Issue Dt:
09/16/2014
Application #:
13703947
Filing Dt:
02/28/2013
Publication #:
US20130202615
Pub Dt:
08/08/2013
Title:
ANTI-VEGF ANTIBODIES AND USES THEREOF
8
Patent #:
8790652
Issue Dt:
07/29/2014
Application #:
13707299
Filing Dt:
12/06/2012
Publication #:
US20130142810
Pub Dt:
06/06/2013
Title:
USE OF THE COMBINATION OF SEMAPHORIN-4D INHIBITORY MOLECULES AND VEGF INHIBITORY MOLECULES TO INHIBIT ANGIOGENESIS
9
Patent #:
9605055
Issue Dt:
03/28/2017
Application #:
13797048
Filing Dt:
03/12/2013
Publication #:
US20140072578
Pub Dt:
03/13/2014
Title:
Anti-CD100 Antibodies and Methods of Using the Same
10
Patent #:
9676840
Issue Dt:
06/13/2017
Application #:
13800713
Filing Dt:
03/13/2013
Publication #:
US20130274449
Pub Dt:
10/17/2013
Title:
Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11
Patent #:
9963504
Issue Dt:
05/08/2018
Application #:
13820278
Filing Dt:
04/19/2013
Publication #:
US20150050287
Pub Dt:
02/19/2015
Title:
ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME
12
Patent #:
9090709
Issue Dt:
07/28/2015
Application #:
13828506
Filing Dt:
03/14/2013
Publication #:
US20140099334
Pub Dt:
04/10/2014
Title:
ANTI-SEMA4D ANTIBODIES AND EPITOPES
13
Patent #:
10494440
Issue Dt:
12/03/2019
Application #:
13842523
Filing Dt:
03/15/2013
Publication #:
US20130302320
Pub Dt:
11/14/2013
Title:
Use of Semaphorin-4D Binding Molecules to Promote Neurogenesis Following Stroke
14
Patent #:
9708601
Issue Dt:
07/18/2017
Application #:
13844388
Filing Dt:
03/15/2013
Publication #:
US20130288927
Pub Dt:
10/31/2013
Title:
Fusion Proteins to Facilitate Selection of Cells Infected with Specific Immunoglobulin Gene Recombinant Vaccinia Virus
15
Patent #:
9447191
Issue Dt:
09/20/2016
Application #:
14117254
Filing Dt:
06/25/2014
Publication #:
US20140303358
Pub Dt:
10/09/2014
Title:
Osteogenesis Promoter
16
Patent #:
9243068
Issue Dt:
01/26/2016
Application #:
14310848
Filing Dt:
06/20/2014
Publication #:
US20150044219
Pub Dt:
02/12/2015
Title:
Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit Tumors and Metastases
17
Patent #:
9890213
Issue Dt:
02/13/2018
Application #:
14382410
Filing Dt:
09/02/2014
Publication #:
US20150125467
Pub Dt:
05/07/2015
Title:
METHODS FOR THE TREATMENT OF B CELL-MEDIATED INFLAMMATORY DISEASES
18
Patent #:
9512224
Issue Dt:
12/06/2016
Application #:
14511679
Filing Dt:
10/10/2014
Publication #:
US20150104462
Pub Dt:
04/16/2015
Title:
Use of Semaphorin-4D Binding Molecules for Treatment of Atherosclerosis
19
Patent #:
9598495
Issue Dt:
03/21/2017
Application #:
14519965
Filing Dt:
10/21/2014
Publication #:
US20150110800
Pub Dt:
04/23/2015
Title:
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerative Disorders
20
Patent #:
9249227
Issue Dt:
02/02/2016
Application #:
14753882
Filing Dt:
06/29/2015
Publication #:
US20150353641
Pub Dt:
12/10/2015
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
21
Patent #:
9790271
Issue Dt:
10/17/2017
Application #:
14765162
Filing Dt:
07/31/2015
Publication #:
US20150368332
Pub Dt:
12/24/2015
Title:
METHODS FOR INCREASING IMMUNOGLOBULIN A LEVELS
22
Patent #:
9828435
Issue Dt:
11/28/2017
Application #:
14892099
Filing Dt:
11/18/2015
Publication #:
US20160115240
Pub Dt:
04/28/2016
Title:
Use of Antibodies or Antigen-Binding Fragments Thereof that Specifically Bind Semaphorin-4D to Increase Tumor Infiltrating Leukocyte Frequency
23
Patent #:
9701958
Issue Dt:
07/11/2017
Application #:
14977067
Filing Dt:
12/21/2015
Publication #:
US20160152971
Pub Dt:
06/02/2016
Title:
METHOD FOR SELECTING POLYNUCLEOTIDES ENCODING ANTIGEN-SPECIFIC IMMUNOGLOBULIN SUBUNITS
24
Patent #:
10301393
Issue Dt:
05/28/2019
Application #:
15173186
Filing Dt:
06/03/2016
Publication #:
US20160376372
Pub Dt:
12/29/2016
Title:
METHOD OF TREATING MULTIPLE SCLEROSIS USING ANTI-CD20 ANTIBODIES
25
Patent #:
10385136
Issue Dt:
08/20/2019
Application #:
15465509
Filing Dt:
03/21/2017
Publication #:
US20170198053
Pub Dt:
07/13/2017
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
26
Patent #:
11274149
Issue Dt:
03/15/2022
Application #:
15581573
Filing Dt:
04/28/2017
Publication #:
US20170306017
Pub Dt:
10/26/2017
Title:
ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME
27
Patent #:
10662422
Issue Dt:
05/26/2020
Application #:
15619790
Filing Dt:
06/12/2017
Publication #:
US20170306318
Pub Dt:
10/26/2017
Title:
METHOD FOR SELECTING POLYNUCLEOTIDES ENCODING ANTIGEN-SPECIFIC IMMUNOGLOBULIN SUBUNIT
28
Patent #:
10526414
Issue Dt:
01/07/2020
Application #:
15666133
Filing Dt:
08/01/2017
Publication #:
US20170335008
Pub Dt:
11/23/2017
Title:
USE OF ANTI-SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASES
29
Patent #:
10829550
Issue Dt:
11/10/2020
Application #:
15953139
Filing Dt:
04/13/2018
Publication #:
US20180244764
Pub Dt:
08/30/2018
Title:
POLYNUCLEOTIDES ENCODING ANTI-CXCL13 ANTIBODIES
30
Patent #:
10577427
Issue Dt:
03/03/2020
Application #:
16091077
Filing Dt:
10/03/2018
Publication #:
US20190112388
Pub Dt:
04/18/2019
Title:
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
31
Patent #:
10640765
Issue Dt:
05/05/2020
Application #:
16384078
Filing Dt:
04/15/2019
Publication #:
US20190241889
Pub Dt:
08/08/2019
Title:
METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS
32
Patent #:
10550199
Issue Dt:
02/04/2020
Application #:
16384087
Filing Dt:
04/15/2019
Publication #:
US20190276556
Pub Dt:
09/12/2019
Title:
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
33
Patent #:
11078295
Issue Dt:
08/03/2021
Application #:
16392451
Filing Dt:
04/23/2019
Publication #:
US20190248914
Pub Dt:
08/15/2019
Title:
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASES
34
Patent #:
11534488
Issue Dt:
12/27/2022
Application #:
16433496
Filing Dt:
06/06/2019
Publication #:
US20190358321
Pub Dt:
11/28/2019
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAIN BARRIER PERMEABILITY
35
Patent #:
10800853
Issue Dt:
10/13/2020
Application #:
16460593
Filing Dt:
07/02/2019
Publication #:
US20190322757
Pub Dt:
10/24/2019
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
36
Patent #:
NONE
Issue Dt:
Application #:
16488123
Filing Dt:
08/22/2019
Publication #:
US20190383836
Pub Dt:
12/19/2019
Title:
EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
37
Patent #:
11572408
Issue Dt:
02/07/2023
Application #:
16496286
Filing Dt:
09/20/2019
Publication #:
US20210179708
Pub Dt:
06/17/2021
Title:
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT
38
Patent #:
11427634
Issue Dt:
08/30/2022
Application #:
16611209
Filing Dt:
11/05/2019
Publication #:
US20210032329
Pub Dt:
02/04/2021
Title:
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
39
Patent #:
10870707
Issue Dt:
12/22/2020
Application #:
16727151
Filing Dt:
12/26/2019
Publication #:
US20200216562
Pub Dt:
07/09/2020
Title:
INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
40
Patent #:
NONE
Issue Dt:
Application #:
16832170
Filing Dt:
03/27/2020
Publication #:
US20200317788
Pub Dt:
10/08/2020
Title:
SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY
41
Patent #:
NONE
Issue Dt:
Application #:
16860217
Filing Dt:
04/28/2020
Publication #:
US20200299683
Pub Dt:
09/24/2020
Title:
METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS
42
Patent #:
11660330
Issue Dt:
05/30/2023
Application #:
16906713
Filing Dt:
06/19/2020
Publication #:
US20200397881
Pub Dt:
12/24/2020
Title:
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 THERAPY
Assignor
1
VACCINEX, INC.
Exec Dt:
08/03/2021
Assignee
1
3I, L.P.
140 BROADWAY, 38TH FLOOR
NEW YORK, NEW YORK 10005
Correspondence name and address
KDB
2601 WESTON PARKWAY, SUITE 103
CARY, NC 27513

Search Results as of: 05/31/2024 09:08 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT